General Information of Drug Off-Target (DOT) (ID: OT5OY8BO)

DOT Name Immediate early response gene 2 protein (IER2)
Synonyms Protein ETR101
Gene Name IER2
Related Disease
Advanced cancer ( )
Lung cancer ( )
Lung neoplasm ( )
Neoplasm ( )
Systemic lupus erythematosus ( )
Venous thromboembolism ( )
UniProt ID
IER2_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF05760
Sequence
MEVQKEAQRIMTLSVWKMYHSRMQRGGLRLHRSLQLSLVMRSARELYLSAKVEALEPEVS
LPAALPSDPRLHPPREAESTAETATPDGEHPFPEPMDTQEAPTAEETSACCAPRPAKVSR
KRRSSSLSDGGDAGLVPSKKARLEEKEEEEGASSEVADRLQPPPAQAEGAFPNLARVLQR
RFSGLLNCSPAAPPTAPPACEAKPACRPADSMLNVLVRAVVAF
Function
DNA-binding protein that seems to act as a transcription factor. Involved in the regulation of neuronal differentiation, acts upon JNK-signaling pathway activation and plays a role in neurite outgrowth in hippocampal cells. May mediate with FIBP FGF-signaling in the establishment of laterality in the embryo. Promotes cell motility, seems to stimulate tumor metastasis.
Tissue Specificity Expressed in activated T-cells (at protein level) . Expression increases in metastatic tumor cells (at protein level) .

Molecular Interaction Atlas (MIA) of This DOT

6 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Advanced cancer DISAT1Z9 Strong Biomarker [1]
Lung cancer DISCM4YA Strong Biomarker [2]
Lung neoplasm DISVARNB Strong Biomarker [2]
Neoplasm DISZKGEW Strong Biomarker [1]
Systemic lupus erythematosus DISI1SZ7 Strong Altered Expression [3]
Venous thromboembolism DISUR7CR Strong Genetic Variation [4]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
25 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate affects the expression of Immediate early response gene 2 protein (IER2). [5]
Ciclosporin DMAZJFX Approved Ciclosporin increases the expression of Immediate early response gene 2 protein (IER2). [6]
Tretinoin DM49DUI Approved Tretinoin increases the expression of Immediate early response gene 2 protein (IER2). [7]
Acetaminophen DMUIE76 Approved Acetaminophen increases the expression of Immediate early response gene 2 protein (IER2). [8]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate increases the expression of Immediate early response gene 2 protein (IER2). [9]
Cisplatin DMRHGI9 Approved Cisplatin decreases the expression of Immediate early response gene 2 protein (IER2). [10]
Estradiol DMUNTE3 Approved Estradiol increases the expression of Immediate early response gene 2 protein (IER2). [11]
Arsenic DMTL2Y1 Approved Arsenic increases the expression of Immediate early response gene 2 protein (IER2). [12]
Quercetin DM3NC4M Approved Quercetin increases the expression of Immediate early response gene 2 protein (IER2). [13]
Arsenic trioxide DM61TA4 Approved Arsenic trioxide affects the expression of Immediate early response gene 2 protein (IER2). [14]
Hydrogen peroxide DM1NG5W Approved Hydrogen peroxide affects the expression of Immediate early response gene 2 protein (IER2). [15]
Carbamazepine DMZOLBI Approved Carbamazepine affects the expression of Immediate early response gene 2 protein (IER2). [5]
Methotrexate DM2TEOL Approved Methotrexate decreases the expression of Immediate early response gene 2 protein (IER2). [16]
Marinol DM70IK5 Approved Marinol decreases the expression of Immediate early response gene 2 protein (IER2). [17]
Azathioprine DMMZSXQ Approved Azathioprine increases the expression of Immediate early response gene 2 protein (IER2). [18]
Bexarotene DMOBIKY Approved Bexarotene decreases the expression of Immediate early response gene 2 protein (IER2). [19]
Urethane DM7NSI0 Phase 4 Urethane increases the expression of Immediate early response gene 2 protein (IER2). [20]
Resveratrol DM3RWXL Phase 3 Resveratrol increases the expression of Immediate early response gene 2 protein (IER2). [21]
Afimoxifene DMFORDT Phase 2 Afimoxifene increases the expression of Immediate early response gene 2 protein (IER2). [11]
phorbol 12-myristate 13-acetate DMJWD62 Phase 2 phorbol 12-myristate 13-acetate increases the expression of Immediate early response gene 2 protein (IER2). [22]
Leflunomide DMR8ONJ Phase 1 Trial Leflunomide increases the expression of Immediate early response gene 2 protein (IER2). [24]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the expression of Immediate early response gene 2 protein (IER2). [25]
Formaldehyde DM7Q6M0 Investigative Formaldehyde increases the expression of Immediate early response gene 2 protein (IER2). [26]
Nickel chloride DMI12Y8 Investigative Nickel chloride increases the expression of Immediate early response gene 2 protein (IER2). [27]
ELLAGIC ACID DMX8BS5 Investigative ELLAGIC ACID increases the expression of Immediate early response gene 2 protein (IER2). [21]
------------------------------------------------------------------------------------
⏷ Show the Full List of 25 Drug(s)
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the methylation of Immediate early response gene 2 protein (IER2). [23]
------------------------------------------------------------------------------------

References

1 The immediate early gene Ier2 promotes tumor cell motility and metastasis, and predicts poor survival of colorectal cancer patients.Oncogene. 2012 Aug 16;31(33):3796-806. doi: 10.1038/onc.2011.535. Epub 2011 Nov 28.
2 Bronchial airway gene expression signatures in mouse lung squamous cell carcinoma and their modulation by cancer chemopreventive agents.Oncotarget. 2017 Mar 21;8(12):18885-18900. doi: 10.18632/oncotarget.13806.
3 Gene profiling involved in immature CD4+ T lymphocyte responsible for systemic lupus erythematosus.Mol Immunol. 2006 Mar;43(9):1497-507. doi: 10.1016/j.molimm.2005.07.039. Epub 2005 Sep 6.
4 Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism.Blood. 2019 Nov 7;134(19):1645-1657. doi: 10.1182/blood.2019000435.
5 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20. doi: 10.1093/toxsci/kfv094. Epub 2015 May 15.
6 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
7 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423. doi: 10.3390/cells9112423.
8 Gene expression analysis of precision-cut human liver slices indicates stable expression of ADME-Tox related genes. Toxicol Appl Pharmacol. 2011 May 15;253(1):57-69.
9 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
10 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
11 Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF. EMBO J. 2009 Mar 4;28(5):523-32.
12 Activation of inflammation/NF-kappaB signaling in infants born to arsenic-exposed mothers. PLoS Genet. 2007 Nov;3(11):e207.
13 Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells. Mutagenesis. 2011 Sep;26(5):593-604.
14 Patterns of gene expressions induced by arsenic trioxide in cultured human fibroblasts. Toxicol Lett. 2003 Jul 20;143(2):155-62. doi: 10.1016/s0378-4274(03)00171-1.
15 Global gene expression analysis reveals differences in cellular responses to hydroxyl- and superoxide anion radical-induced oxidative stress in caco-2 cells. Toxicol Sci. 2010 Apr;114(2):193-203. doi: 10.1093/toxsci/kfp309. Epub 2009 Dec 31.
16 Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium. Arthritis Rheumatol. 2014 Jan;66(1):15-23.
17 Single-cell Transcriptome Mapping Identifies Common and Cell-type Specific Genes Affected by Acute Delta9-tetrahydrocannabinol in Humans. Sci Rep. 2020 Feb 26;10(1):3450. doi: 10.1038/s41598-020-59827-1.
18 A transcriptomics-based in vitro assay for predicting chemical genotoxicity in vivo. Carcinogenesis. 2012 Jul;33(7):1421-9.
19 Identification of biomarkers modulated by the rexinoid LGD1069 (bexarotene) in human breast cells using oligonucleotide arrays. Cancer Res. 2006 Dec 15;66(24):12009-18.
20 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
21 Interactive gene expression pattern in prostate cancer cells exposed to phenolic antioxidants. Life Sci. 2002 Mar 1;70(15):1821-39.
22 Expression of endogenous retroviruses reflects increased usage of atypical enhancers in T cells. EMBO J. 2019 Jun 17;38(12):e101107. doi: 10.15252/embj.2018101107. Epub 2019 May 8.
23 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
24 Endoplasmic reticulum stress and MAPK signaling pathway activation underlie leflunomide-induced toxicity in HepG2 Cells. Toxicology. 2017 Dec 1;392:11-21.
25 Bisphenol A induces DSB-ATM-p53 signaling leading to cell cycle arrest, senescence, autophagy, stress response, and estrogen release in human fetal lung fibroblasts. Arch Toxicol. 2018 Apr;92(4):1453-1469.
26 Regulation of chromatin assembly and cell transformation by formaldehyde exposure in human cells. Environ Health Perspect. 2017 Sep 21;125(9):097019.
27 Classification of heavy-metal toxicity by human DNA microarray analysis. Environ Sci Technol. 2007 May 15;41(10):3769-74.